Delivery Order SPE2DB22D9367-SPE2DB25FSY83
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $12,782.32 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Alecensa 150 mg capsules (240-unit quantity). This firm fixed-price delivery order, issued on September 3, 2025, with an ultimate completion date of September 24, 2025, carries no set-aside designation. The award falls under DMS Pharmaceutical Group's existing single-award Indefinite...
- The Defense Logistics Agency awarded a $25.6K firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 240 units of Alecensa 150 mg capsules. The contract was awarded on September 18, 2025, with an ultimate completion date of October 9, 2025, and carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA valued...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Alecensa 150 mg capsules (240-count units). This firm fixed-price delivery order, awarded on July 21, 2025, carries a ceiling value of $12,782.32 and is scheduled for ultimate completion by August 11, 2025. The contract was awarded without a set-aside designation, allowing DMS Pharmaceutical Group to compete...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency for 240 capsules of Alecensa 150 mg on June 26, 2025. The contract is valued at $12,782.32 under a firm fixed-price delivery order structure with an ultimate completion date of July 18, 2025. This award was made without a set-aside designation, allowing the company to compete on an unrestricted basis. The place of...
- The Defense Logistics Agency awarded a $12.78K delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Alecensa 150 mg capsules (240 count). The contract, issued on August 5, 2025, with an ultimate completion date of August 26, 2025, represents a firm fixed-price delivery order with no set-aside designation. This award is issued under DMS Pharmaceutical Group's existing single-award Indefinite...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $38,346.96 on September 18, 2025, for the supply of Alecensa 150 mg capsules (240 units). The award was issued without a set-aside designation by the Medical Supply Chain division of the Defense Logistics Agency and is scheduled for ultimate completion by October 9, 2025. This delivery order falls under the company's larger...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a delivery order from the Defense Logistics Agency for 240 units of Alecensa 150 mg capsules, valued at $21,731.14. This firm fixed-price delivery order, awarded on August 4, 2025, with an ultimate completion date of August 25, 2025, carries no set-aside designation. The award represents one of numerous delivery orders issued under DMS Pharmaceutical Group's larger...
- The Defense Logistics Agency awarded a delivery order valued at $12,782.32 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Alecensa 150 mg capsules (240-count units). This firm fixed-price delivery order, issued on August 8, 2025, with an ultimate completion date of August 29, 2025, represents a direct procurement for pharmaceutical products supporting Department of Defense healthcare needs. The contract...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $51,129.28 on July 18, 2025, for Alecensa 150 mg capsules (240-count units) under a Defense Logistics Agency contract. This firm fixed-price delivery order, with an ultimate completion date of August 8, 2025, represents a single transaction within DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $49,897.20 contract is for the delivery of Alecensa 150 mg capsules. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999, which enables the DLA to issue delivery orders for a comprehensive range of pharmaceutical products to support the medical...
- SPE2DB22D9367Indefinite Delivery Contract
- SPE2DB22D9367-SPE2DB25FSY83Delivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order by the Defense Logistics Agency (DLA) on July 14, 2025, for the supply of Alecensa 150 mg capsules (240-count units) with a ceiling value of $25.6K. This delivery order, which carries no set-aside designation, is scheduled for completion by August 4, 2025, and will be performed at the contractor's facility in Park Ridge, Illinois. The award represents a single procurement action under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the DLA, valued at $500M through November 2026, which enables the agency to issue firm fixed-price delivery orders for pharmaceutical products supporting military healthcare facilities nationwide. This delivery order exemplifies the contractor's established role as a critical supplier within the federal pharmaceutical supply chain. DMS Pharmaceutical Group has demonstrated consistent success in competing for pharmaceutical procurement opportunities with the DLA, leveraging its woman-owned small business status and comprehensive inventory of branded and generic prescription drugs, specialty medications, and medical consumables. The Alecensa order fulfills the Defense Department's ongoing need for oncology and specialty pharmaceutical products to support military health system requirements across installations worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $25.6k | 7/14/25 |